ISMP's draft guidelines for safe use of subcutaneous insulin are open for public comment. Please visit this link (http://www.ismp.org/Tools/guidelines/SUSI/Default.aspx) to view and provide comments on the consensus statements. We appreciate your comments by Saturday April 30, 2016. This is the final opportunity to weigh in on the guidelines. We appreciate your commitment to safe medication use and look forward to reviewing your feedback.